文献速递免疫规划

低剂量四价流感疫苗Grippol Quadrivalent含Polyoxidonium佐剂诱导Th2型体液免疫并增强NK细胞活性

Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity.
PubMed 文献 · Vaccine · 2020-08-29

该研究在小鼠模型中评价了含Polyoxidonium佐剂的低剂量四价流感疫苗GQ的免疫应答。GQ可诱导针对4种流感血凝素的抗体,增强Th2细胞因子产生和CD4+记忆T细胞积聚,并提高NK细胞杀伤活性,而佐剂 free 抗原混合物对NK活性无影响。

要点

  • GQ疫苗含Polyoxidonium佐剂,每剂每种血凝素5-6 μg,约为WHO推荐标准剂量的1/3。
  • GQ诱导针对全部4种流感血凝素的抗体,并增强Th2型细胞因子应答和CD4+记忆T细胞积聚。
  • GQ增强NK细胞杀伤活性,而佐剂 free 抗原混合物在降低和标准剂量下均不影响NK活性。

核心结论

  • 低剂量流感疫苗GQ含Polyoxidonium佐剂具有免疫原性,诱导Th2极化T细胞应答和CD4+记忆T细胞成熟,激活抗血凝素抗体产生并增强NK细胞活性。

研究设计与样本

  • BALB/c小鼠接种GQ疫苗或佐剂 free 抗原混合物(AGs),随后检测抗体应答、脾脏记忆T细胞数量及脾细胞功能特性。

主要发现

  • GQ疫苗诱导针对全部4种流感血凝素的抗体。
  • GQ接种引起AG诱导的增殖和Th2细胞因子产生在离体条件下强烈增加,效果与标准剂量抗原相当。
  • GQ接种导致脾脏中具有中央和效应记忆T细胞表型的CD4+大淋巴细胞积聚。
  • GQ疫苗增强自然杀伤(NK)细胞的杀伤活性,而佐剂 free 抗原混合物在降低和标准剂量下均不影响NK活性。
  • 未发现对疫苗接种的明显Th1和CD8+ T细胞应答;体外GQ疫苗刺激人单核细胞来源树突状细胞(DCs)成熟,增强HLA-DR、CD80、CD83、CD86和ICOSL分子表达。

关键数值与推荐

  • GQ疫苗每剂含4株流感病毒重组血凝素各5-6 μg,约为WHO推荐标准剂量的1/3。
  • Polyoxidonium佐剂在不含抗原时也诱导ICOSL表达,ICOSL在T依赖性体液免疫应答中起重要作用。

临床怎么用

  • 该研究为动物实验,提示含Polyoxidonium佐剂的低剂量四价流感疫苗可诱导Th2偏向的体液免疫和NK细胞活化,支持进一步临床评价。

局限性

  • 研究仅在小鼠中进行,人体免疫原性和保护效果需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The influenza vaccine Grippol® Quadrivalent (GQ) is a new vaccine, containing the adjuvant Polyoxidonium® and recombinant hemagglutinins from 4 strains of the influenza virus in amount of 5-6 μg of each hemagglutinin per human dose. These doses of antigens are about 3 times less than the standard dose recommended by WHO. We sought to characterize the immune response to the GQ vaccine and to determine the contribution of the adjuvant in this response. BALB/c mice were vaccinated with GQ or with adjuvant-free antigen mixtures (AGs). Then, the antibody response, the number of memory T cells in the spleen, and the functional properties of splenocytes were determined. The vaccine GQ has been shown to induce antibodies to all 4 influenza hemagglutinins. The vaccination with GQ caused a strong increase in the AG-induced proliferation and production of Th2 cytokines ex vivo. These effects were equal to effect achieved by standard dose of antigens. Vaccination also caused the accumulation of CD4+ large lymphocytes with the phenotype of central and effector memory T cells in the spleen. The GQ vaccine enhanced the cytolytic activity of natural killer (NK) cells, whereas the adjuvant-free mixture of AGs in lowered and standard doses did not affect NK activity. We did not find a noticeable response of Th1 and CD8+ T cells to vaccination. In vitro, the GQ vaccine stimulated the maturation of human monocyte-derived dendritic cells (DCs) enhancing the expression of HLA-DR, CD80, CD83, CD86 and ICOSL molecules. Polyoxidonium without AGs also induced expression of ICOSL, which plays an important role in T-dependent humoral immune response. In summary, the low-dose influenza vaccine GQ with Polyoxidonium adjuvant is immunogenic, induces a Th2-polarized T-cell response and CD4+ memory T cells maturation, activates the production of antibodies to influenza hemagglutinins, and increases the activity of NK cells.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Talayev V, Zaichenko I, Svetlova M, et al. Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity. Vaccine. 2020. PMID: 32873403. doi:10.1016/j.vaccine.2020.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。